Role of the IL-33-ST2 axis in sepsis

Hui Xu; Heth R. Turnquist; Rosemary Hoffman; Timothy R. Billiar

Your Location：

Home >

Browse articles >

Role of the IL-33-ST2 axis in sepsis

REVIEW | Updated：2022-12-27

Previous|Next

- Role of the IL-33-ST2 axis in sepsis
- Hui Xu , Heth R. Turnquist , Rosemary Hoffman , Timothy R. Billiar
- Military Medical Research Vol. 4, Issue 1, Pages: 50-60(2017)
- Affiliations：
  1.Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA
  2.State Key Laboratory of Oral Diseases, Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  3.Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
- Author bio：
  *: billiartr@upmc.edu
- Funds：
- DOI：
  CLC：
- Accepted：
Scan QR Code
DOI：
DOI：

Full Text(HTML)
Figs( 2 ) Tabs( 1 )
References
Publication Info
Metrics

摘要

Abstract

关键词

Keywords

references

20

Views

58

Downloads

0

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

A call for further evidence regarding the association between metabolic syndrome, sepsis, and sepsis-related death

The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis

ZBP1 activated by mitochondrial damage binds to STAT3 to suppress Legumain production and exacerbate macrophage inflammation in Klebsiella pneumoniae-induced sepsis

Related Author

Shao-Yu Liu

Shao-Kang Xu

Jing-Li Gao

Xiao-Ke Kong

Jian Shi

Ya Miao

Yi-Ting Tang

Bin Zhao

Related Institution

Department of Critical Care Medicine and Hematology, the Second Xiangya Hospital, Central South University

Department of Critical Care Medicine and Hematology, the Third Xiangya Hospital, Central South University

Department of Intensive Medicine, Kailuan General Hospital

National Clinical Research Center for Endocrine and Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University

CSU-Sinocare Research Center for Nutrition and Metabolic Health, Xiangya School of Public Health, Central South University; Furong Laboratory